Data is not available at this time.
Create SD Holdings Co., Ltd. operates as a diversified healthcare services provider in Japan, primarily focusing on drug retail, pharmacy dispensing, and nursing care. The company generates revenue through its extensive network of drugstores, which sell pharmaceuticals, cosmetics, food products, and daily necessities, catering to both general consumers and patients. Its vertically integrated model includes dispensing pharmacies, ensuring steady demand from prescription-based customers. Additionally, the company operates nursing homes and functional training centers, addressing Japan’s aging population needs. This dual focus on retail and care services positions Create SD Holdings as a resilient player in Japan’s healthcare sector, benefiting from demographic tailwinds and regulatory support for community-based care. The company’s competitive edge lies in its localized store presence, operational efficiency, and ability to cross-sell products across its retail and care segments. While facing competition from larger pharmacy chains and e-commerce players, its integrated approach and focus on underserved regional markets provide stability and growth potential.
Create SD Holdings reported revenue of ¥422.3 billion for FY 2024, reflecting its strong market presence in Japan’s drug retail and care sectors. Net income stood at ¥13.7 billion, with diluted EPS of ¥215.6, indicating stable profitability. Operating cash flow of ¥21.0 billion underscores efficient working capital management, though capital expenditures of ¥16.2 billion suggest ongoing investments in store expansion and care facilities.
The company demonstrates consistent earnings power, supported by recurring revenue from pharmacy dispensing and care services. Its capital efficiency is evident in its ability to maintain profitability while expanding its store network. With minimal total debt (¥1 million) and robust cash reserves (¥38.2 billion), Create SD Holdings is well-positioned to fund growth initiatives without significant leverage.
Create SD Holdings maintains a strong balance sheet, with ¥38.2 billion in cash and equivalents and negligible debt, reflecting a conservative financial strategy. This low-leverage profile provides flexibility for strategic investments or acquisitions. The company’s asset-light model in retail and care services further supports its financial stability.
The company benefits from structural growth drivers, including Japan’s aging population and increasing healthcare demand. Its dividend per share of ¥71 signals a commitment to shareholder returns, though payout ratios remain sustainable given its earnings and cash flow. Future growth may hinge on regional expansion and operational scaling in nursing care.
With a market cap of ¥202.2 billion and a beta of 0.34, Create SD Holdings is viewed as a defensive play in Japan’s healthcare sector. Its valuation reflects steady cash flows and low volatility, though growth expectations are tempered by the mature nature of its core markets.
Create SD Holdings’ integrated retail and care model provides resilience against economic cycles. Its focus on regional markets and aging demographics positions it for long-term growth, though competition and regulatory changes remain key risks. The company’s strong balance sheet and cash flow generation support continued investments in store optimization and care service expansion.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |